ArticleCancer nanotechnology2026
Quercetin-Fe nanodots inhibit cervical cancer cell proliferation by targeting PCNA.
Article in Cancer nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Extracellular vesicles in colorectal cancer: immunomodulation, diagnostics, and therapeutic perspectives.Medical oncology (Northwood, London, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The targets and active components that affect the prognosis of cervical cancer remain unclear. Methods: Three microarray datasets were collected for differentially expressed genes (DEGs) screening. The pathway, function, protein interaction and prognosis were analysed. The active components, related targets, the active ingredient-target gene network were conducted. The protein expression of the hub gene was validated through immunohistochemistry and Nanodrugs Que-Fe NDs were prepared and validated by in vitro cellular functionalization experiment. Results: 162 upregulated and 145 downregulated DEGs were screened out, including 10 hub genes, which were mainly clustered in DNA replication, cell division, proliferation, and cycle. The results of active ingredient-target gene network showed that the traditional Chinese medicine quercetin has the potential therapeutic effect on cervical cancer via targeting PCNA. Experiments focused on cellular functionalization demonstrated that the synthesized Que-Fe nanodots (NDs) were capable of decreasing the levels of proliferating cell nuclear antigen (PCNA) expression and suppressing the in vitro proliferation of HeLa cells. Conclusion: The growth of cervical cancer HeLa cells was suppressed in vitro by Que-Fe NDs. This finding indicates a promising novel therapeutic target that warrants additional investigation. Supplementary Information: The online version contains supplementary material available at 10.1186/s12645-025-00353-y.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.